MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
August 7, 2006
Stephen D. Simpson
Advanced Medical Optics Still a Little Bloodshot This eye-care stock has done relatively well despite some ongoing sales issues. mark for My Articles similar articles
The Motley Fool
November 2, 2005
Stephen D. Simpson
AMO Focuses on the Giants Advanced Medical Optics sets its sights on the big players in eye care. Will David be able to take on the Goliaths? Investors, take note. mark for My Articles similar articles
The Motley Fool
January 23, 2006
Stephen D. Simpson
II-VI Ailing Lower sales and higher costs lead to a tough quarter for this laser components maker. mark for My Articles similar articles
The Motley Fool
January 30, 2006
Rich Smith
Foolish Forecast: American Standard American Standard's gross margin, which wasn't impacted at all by restructuring charges, has remained strong -- even growing slightly. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 22, 2004
Nathan Slaughter
VISX Eyes Future The vision-correction firm posts triple-digit earnings growth, capturing the attention of investors. mark for My Articles similar articles
The Motley Fool
February 1, 2006
Rich Smith
Foolish Forecast: International Page Turner Investors, look for signs that restructuring has produced a leaner and meaner International Paper, one that can execute more efficiently in the coming quarters. mark for My Articles similar articles
The Motley Fool
February 23, 2005
Stephen D. Simpson
LCA-Vision Focuses on Profit The provider of laser vision correction is aggressive, but the market is ripe for consolidation. Despite the company's rocketing growth and an equally hot stock, valuation isn't too bad. mark for My Articles similar articles
The Motley Fool
February 9, 2006
Stephen D. Simpson
Alcon Makes Traders Cry Disappointing guidance lets some of the air out of the valuation, but not enough. mark for My Articles similar articles
The Motley Fool
January 12, 2009
Brian Orelli
Abbott Eyes New Growth Abbott announces it's buying eye-care specialist Advanced Medical Optics for $22 per share -- nearly 150% higher than Friday's close on the stock. mark for My Articles similar articles
The Motley Fool
October 20, 2005
Stephen D. Simpson
Wide Eyes at Alcon Excellent margin performance fueled exceptional growth for this eye-care titan. This is a strong and valuable cash-producing franchise, and it deserves a premium valuation -- but how much of a premium? mark for My Articles similar articles
The Motley Fool
April 21, 2005
Stephen D. Simpson
Can Diebold Produce Bold Growth? This business seems like it should be doing better than it is. Recent growth trends have been pretty anemic. What's more, the company seems to be budgeting restructuring charges into its ongoing guidance. mark for My Articles similar articles
The Motley Fool
July 25, 2006
Stephen D. Simpson
An Eye-Opening Quarter at Alcon Good news may have been overdue from the eye-care company, but the jubilation seems overdone. Investors, take note. mark for My Articles similar articles
The Motley Fool
August 10, 2010
Seth Jayson
Marginal Performance at Alcon The more Alcon keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. mark for My Articles similar articles
The Motley Fool
October 12, 2005
W.D. Crotty
A Quarter That's Hard to Rectify Power management company International Rectifier forecasts a first quarter that will miss guidance. I wouldn't call Wall Street wrong for discounting this company. mark for My Articles similar articles
The Motley Fool
August 9, 2005
Stephen D. Simpson
Is II-VI Still Beaming? Fourth-quarter performance and guidance were both solid for the laser optics maker, but the underlying bookings figures weren't quite as strong. Looking ahead, investors might want to keep an eye on the balance sheet. mark for My Articles similar articles
The Motley Fool
May 1, 2006
Stephen D. Simpson
Alcon Still Not Living Up to Valuation Though this is a very solid medical technology company, its valuation still looks too high. mark for My Articles similar articles
BusinessWeek
May 17, 2004
Gene G. Marcial
Take a Closer Look At Eye-Opening VISX One super highflier last year was VISX, the top developer of technologies for laser vision correction, and may be poised for a second wave as some pros are arguing it could hit at least $30 this year. mark for My Articles similar articles
The Motley Fool
September 14, 2007
Michael Goode
Brady Buys a Bunch The manufacturing conglomerate grows through acquisitions, but restructuring charges hurt its net. mark for My Articles similar articles
The Motley Fool
October 25, 2005
Stephen D. Simpson
LCA-Vision Sees Clearly Now Growing share in a growing market provides a one-two punch for earnings at the laser vision correction specialist. Investors may want to wait for a stumble before buying in. mark for My Articles similar articles
InternetNews
May 4, 2005
Tim Gray
IBM to Cut up to 13,000 Jobs IBM said it will lay off up to 13,000 employees in Europe as part of a restructuring plan to address a sagging global revenue picture. mark for My Articles similar articles
The Motley Fool
August 24, 2010
David Meier
Could Alcon Be a Multibagger? Strong returns on equity can generate powerful shareholder returns. mark for My Articles similar articles
BusinessWeek
September 29, 2003
Bremner & Kunii
Corporate Japan's Stealth Makeover Companies are pushing through tough restructuring. mark for My Articles similar articles
The Motley Fool
November 22, 2006
Anders Bylund
A Little Less Talk, a Little More Action at Tech Data Any small improvement from this IT product distributor stands to bring in huge benefits for shareholders. mark for My Articles similar articles